Krystal Biotech, Inc.

KRYSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$389.1M

▲ 33.9% YoY

Net Income

$204.8M

▲ 129.7% YoY

EPS

$6.84

▲ 128.0% YoY

Cash

$496.3M

▲ 43.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.